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Abstract
Progress in functional and structural studies of integral membrane proteins (IMPs) is lacking behind their soluble
counterparts due to the great challenge in producing stable and homogeneous IMPs. Low natural abundance, toxicity when
over-expressed and potential lipid requirements of IMPs are only a few reasons for the limited progress. Here, we describe
an optimised workflow for the recombinant over-expression of the human tetraspan vesicle protein (TVP) synaptogyrin in
Escherichia coli and its biophysical characterisation. TVPs are ubiquitous and abundant components of vesicles. They are
believed to be involved in various aspects of the synaptic vesicle cycle, including vesicle biogenesis, exocytosis and
endocytotic recycling. Even though TVPs are found in most cell types, high-resolution structural information for this class of
membrane proteins is still missing. The optimisation of the N-terminal sequence of the gene together with the usage of the
recently developed Lemo21(DE3) strain which allows the balancing of the translation with the membrane insertion rate led
to a 50-fold increased expression rate compared to the classical BL21(DE3) strain. The protein was soluble and stable in a
variety of mild detergents and multiple biophysical methods confirmed the folded state of the protein. Crosslinking
experiments suggest an oligomeric architecture of at least four subunits. The protein stability is significantly improved in the
presence of cholesteryl hemisuccinate as judged by differential light scattering. The approach described here can easily be
adapted to other eukaryotic IMPs.
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Introduction
Integral membrane proteins (IMPs) are notoriously difficult to
study. The lack of structural data is just one consequence of the
challenges they confront us with: toxicity to their over-production
host, lipid requirements for correct folding and function,
detergents destabilising the IMPs and hampering the formation
of well-ordered crystals [1].
Since the natural abundance of IMPs is usually low, they need
to be over-expressed in a recombinant system. To be able to isolate
sufficient material for structural and functional studies the choice
of the over-expression host is critical [2]. Bacteria such as
Escherichia coli are preferred since they are well studied, genetically
accessible and can produce a large biomass in time and cost
effective manner [3,4]. As a consequence, the E. coli BL21(DE3)
strain is the most widely used protein production system. In
BL21(DE3) the expression of the target gene is directed by the T7
RNA polymerase [5], a polymerase 8 times faster than the E. coli
RNA polymerase [6]. The strain was designed for rapid and
efficient protein production [5]. However, over-expression of
IMPs is often toxic to cells. A too fast transcription/translation rate
seems to lead to saturation of the bacterial membrane protein
insertion machinery, the Sec translocon [7,8]. Therefore an E. coli
strain, Lemo21(DE3), was recently engineered to balance expres-
sion speed with the cell’s capacities by titrating the T7 RNA
polymerase activity [9]. In practice, the production of IMPs in a
homogeneous and functional form still requires time consuming
screening of many different conditions.
Here we present a comprehensive over-expression optimisation
screening strategy and the biophysical characterisation of a human
IMP over-expressed in E. coli. The strategy has been applied for
synaptogyrin, an IMP which belongs to the tetraspan vesicle
membrane proteins (TVPs). TVPs have four transmembrane
segments and cytoplasmically located termini, and are highly
abundant components of different vesicle types [10–13]. They can
be grouped into three distinct families that are referred to as
physins, gyrins and secretory carrier associated membrane
proteins (SCAMPs). They are encoded by multigene classes in
mammals and are evolutionary conserved throughout the animal
kingdom [10,14]. Numerous roles of TVPs in various aspects of
the (synaptic) vesicle cycle, including vesicle biogenesis, exocytosis
and endocytotic recycling [10,14] are suggested. Furthermore,
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38244multiple interactions of TVPs with lipids (mainly cholesterol)
[15,16], the dopamine transporter [17] and various components of
the recycling machinery like the soluble N-ethylmaleimide
sensitive fusion attachment protein receptors and syntaxin
(SNAREs) [18–21], dynamin [22–24], eps15 homology (EH)-
domain proteins [25] have been described. The observation of
mild or even absent phenotypic defects in neurons of mice lacking
synaptogyrin 1, synaptophysin or SCAMP 1 is intriguing [14,26–
30]. Combined knockouts of the genes encoding synaptophysin
and synaptogyrin lead to changes in synaptic plasticity in mice,
whereas a triple mutant (synaptogyrin 1, synaptophysin 1, SCAMP
1) in Caenorhabditis elegans is lacking profound nervous system
defects [14].
Figure 1. Topology model, construct design and sequence comparison of synaptogyrin. (A) Topology model and schematic
representation of human TVP synaptogyrin in the vesicle membrane. Both, N- and C-termini are predicted to face the cytoplasm. Transmembrane
domains are indicated. (B) Synaptogyrin constructs designed for this over-expression study. Additional amino acid residues and affinity tags provided
by the vector backbone are color coded. (C) Sequence comparison of the synaptogyrin members 1–3 including isoforms a-c from synaptogyrin 1.
Identical and similar residues are color coded in red. The disulfide bridge in vesicular loop 1, a highly conserved arginine in loop 2 and possible
phosphorylation sites in the C-terminal part are indicated. Synaptogyrin members show greatest variability in the cytoplasmic C-terminal tail.
Synaptogyrin 1 isoforms b and c lack possible phosphorylation sites.
doi:10.1371/journal.pone.0038244.g001
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encoding synaptogyrin 1 were identified in schizophrenia patients
suggesting that aberrant synaptogyrin 1 function may be involved
in the pathogenesis of schizophrenia [31–34]. Despite these
findings the understanding of synaptogyrin in the synaptic vesicle
cycle is far from complete. To study the structural and functional
role of synaptogyrin further we have established an over-
expression platform for different synaptogyrin isoforms. The
combination of synaptogyrin construct optimisation and the usage
of the recently described E. coli strain Lemo21(DE3) improved
expression levels from micrograms to several milligrams per liter of
E. coli culture, sufficient for structural studies. A number of
biophysical techniques validated that the recombinant expressed
synaptogyrin 1 was homogeneous and properly folded. Cross-
linking experiments support an oligomeric assembly in the
membrane and in detergent solubilised form with at least four
subunits. The purified protein is significantly stabilised against heat
denaturation in the presence of cholesteryl hemisuccinate. The
strategy for improving eukaryotic IMP over-expression in E. coli
provided here can easily be adapted to other IMPs.
Results
Cloning and construct design
The schematic representation of the synaptogyrin family is
shown in figure 1A [10,35–39]. All synaptogyrin members are
composed of a short N-terminal cytoplasmic sequence, four
homologous transmembrane segments and a variable cytoplasmic
C-terminal tail that is tyrosine phosphorylated (number and
position arbitrary). A 38 amino acid stretch within the C-terminal
region of synaptogyrin 1 and a single arginine residue in the
cytoplasmic loop 2 are required for its correct targeting [37].
Paired cysteines are present in the intravesicular loop 1 of all
family members. The high sequence similarity between synapto-
gyrin isoforms is mainly due to the highly conserved transmem-
brane domains, whereas major differences appear in the N- and C-
terminal residues (Figure 1C). Furthermore, the splice forms
synaptogyrin 1b and 1c have shortened C-termini compared to
synaptogyrin 1a, synaptogyrin 2 and synaptogyrin 3, which are
predicted to be in random coil conformations [40]. Synpatogyrin
1b, 2 and 3 were chosen for a detailed over-expression study in E.
coli. The genes encoding the different synaptogyrin variants were
initially cloned into the pTH24 vector using the Gateway cloning
system from the human Orfeome collection (see ‘‘Materials and
Methods’’ section for details). This robust and high throughput
compatible cloning system however adds additional 12 residues N-
terminal and 40 residues C-terminal of the target protein which is
not desired for structural studies. Therefore additional N-terminal
deletion constructs of synaptogyrin 1b were designed as shown in
Figure 1B. The synaptogyrin 1b gene was shortened from the N-
terminus and a TEV cleavage site was introduced in front of the
C-terminal His tag. Furthermore construct 5 of synaptogyrin 1
contained a cleavable N-terminal His tag and no additional
residues at the C-terminus.
Expression screening
Three different E. coli strains (BL21(DE3), C41(DE3) and
Rosetta2(DE3)) were chosen for initial expression screening.
Expression trials revealed very low expression levels of the IMPs
at induction temperatures above 25uC (data not shown). Highest
expression yields were obtained at 20uC and cells were harvested
16 hours after induction. Prepared membranes were normalised
according to the final OD600 nm value and expression levels were
quantified via Western blot analysis (Figure 2A). Expression levels
of the synaptogyrin 1 constructs varied significantly. The
Rosetta2(DE3) strain performed best although the obtained
biomasses of the different over-expression cultures, reflected in
the lowest OD600 nm values, were the lowest (Figure 2B). Most
dramatic reduction of the expression levels for synaptogyrin 1 was
caused by removing the 12 additional N-terminal residues
provided by the plasmid backbone (compare construct 1 and
construct 3), an observation we have made for a number of IMPs
(unpublished results). However, placing a codon optimised His tag
at the N-terminus including a TEV cleavage site (construct 5)
yielded 40% of expression level compared to construct 1 and 2.
This construct is preferred for structural studies since only one
additional residue remains on the protein after removal of the His
tag. Based on the large differences of over-expression performanc-
es in different E. coli strains we extended the expression screening
repertoire by the second ‘‘Walker strain’’ C43(DE3) [41] and the
newly developed Lemo21(DE3) expression system [9]. The latter
controls the activity of T7 RNA polymerase by its natural
inhibitor, the T7 lysozyme, which is encoded on an additional
plasmid under the control of a titratable rhamnose promoter. With
this system it is possible to balance expression rate with membrane
insertion capacity to minimise potential toxic effects of membrane
protein over-expression and thus to increase the overall expression
yield. Indeed, dependent on the target proteins, different
rhamnose concentrations were identified for optimal expression
levels [9] (Figure 3). For the N-terminal His tagged construct of
synaptogyrin 1b (construct 5) an 8-fold increase in expression level
per cell compared to the best expressing E. coli strain Roset-
ta2(DE3) was found for Lemo21(DE3) in the presence of 250 mM
rhamnose (Figure 3A). Expression levels in the presence of lower
rhamnose concentrations are reduced probably due to the
jamming of the translocon. Higher rhamnose concentrations
presumably lead to too low activity of the T7 RNA polymerase
resulting in reduced yields. Surprisingly, none of the ‘‘Walker
strains’’, C41(DE3) and C43(DE3), originally isolated for their
improved membrane protein over-expression characteristics
showed increased expression levels for any of the synaptogyrin
constructs. The effects for synaptogyrin 2 and 3 were less dramatic
(Figure 3B,C). While synaptogyrin 2 showed an 2-fold increase in
expression in Lemo21(DE3), the Rosetta2 strain remained the best
over expression host for synaptogyrin 3. Besides the increased
expression levels per cell for synaptogyrin 1 and 2, the resulting
biomass reflected in the higher OD600 nm values was also
significantly increased for the Lemo21(DE3) system compared
the Rosetta2(DE3) strain. Overall, an almost 20-fold increase in
total synaptogyrin 1 (construct 5) over-expression level was
obtained.
Detergent solubilisation screening and quality control
The expression levels for the synaptogyrin variants in different
E. coli strains were determined after membrane preparations
indicating that the recombinantly expressed IMP is either inserted
or associated with the membrane fraction. This however does not
give any information on the quality of the over-expressed material.
In contrast to soluble proteins, where incorrectly folded proteins
usually precipitate and end up as inclusion bodies, the situation for
IMPs is different: Over-expressed IMPs can be targeted to and
inserted into or associated with the membrane, which does not
automatically ensure that the protein has reached the native folded
state. Initial quality information can be obtained by solubilisation
screening. Prepared membranes from E. coli strains showing the
highest expression level for synaptogyrin 1, 2 and 3 according to
Western blot analysis, were solubilised in eight different detergents
generally used in IMP biochemistry and the solubilisation
Biophysical Characterisation of Synaptogyrin 1
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e38244Figure 2. Over-expression of synaptogyrin constructs. (A) Relative over-expression yields of the synaptogyrin constructs in different
expression strains determined via Western blot after crude membrane preparation using a HRP-conjugated His probe. Construct with the highest
Western blot intensity was set to 100 percent. Error bars are derived from three independent Western blots to minimise errors caused by inefficient
transfer of IMPs from the SDS gels onto the membrane. (B) Final optical density of the synaptogyrin constructs in the corresponding expression strain
prior to harvest.
doi:10.1371/journal.pone.0038244.g002
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and Methods’’ section). High solubilisation efficiencies in mild
detergents such as DDM, DM, C12E8 or Triton X-100 are already
a good indication for a properly folded IMP. On the other hand, if
solubilisation is only successful in harsh detergents such as FC12 or
LDAO, which are able to solubilise precipitated material [42],
there is a high risk that the IMP is not functionally folded in the
membrane. Interestingly, the solubilisation efficiencies vary for
different synaptogyrin isoforms and constructs (Figure 4). Just
about 50% of the over-expressed material of synaptogyrin 1
constructs with a C-terminal His tag could be solubilised in mild
detergents, while the N-terminally tagged constructs expressed
either in the Rosetta2(DE3) or Lemo21(DE3) strain was almost
100% soluble in all detergents tested (Figure 4A). Observations for
the synaptogyrin 2 construct are very similar compared to
synaptogyrin 1 (Figure 4B). For synaptogyrin 3 the situation is
different: Less than 15% of the over-expressed material was
soluble in detergents other than FC12 or LDAO indicative of
poorly folded and instable material (Figure 4C).
To characterise the solubilised material further, the different
DDM solubilised synaptogyrin 1 constructs were purified via
affinity chromatography and analysed by analytical gel filtration
(Figure 5). Synaptogyrin 1 constructs elute as a monodisperse
symmetrical peak typical for a homogeneous protein preparation
(Figure 5A). Based on the high quality and expression level in
Lemo21(DE3) the N-terminally His tagged synaptogyrin 1
construct was used for further evaluation (construct 5). As already
indicated in the solubilisation screen, synaptogyrin 1 could be
solubilised in various detergents and remained monodisperse
during the gel filtration run (Figure 5B).
Results obtained from the small-scale expression screening
translated very well in large scale expression and purification as
shown in Figure 6. Five milligrams of purified synaptogyrin 1 were
obtained per liter of culture after IMAC chromatography and
preparative gel filtration. The protein remained stable without any
obvious precipitation at room temperature for one week and could
be concentrated above 20 mg/ml.
Figure 3. Lemo21(DE3) as over-expression host for synaptogyrin. (A) Over-expression yields of synaptogyrin 1b construct 5 as quantified by
Western blot of crude membranes in different over-expression strains. The different rhamnose concentrations used with the Lemo21(DE3) strain are
indicated. Expression strain with the highest expression level was set to 100 percent Western blot intensity. Lower panel shows the final OD600 nm
values reached before harvest. (B) Same as in (A) but data are shown for the synaptogyrin 2 construct. (C) Over-expression results for synaptogyrin 3
as described for (A). Error bars are derived from three independent Western blot analyses.
doi:10.1371/journal.pone.0038244.g003
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TVPs are predicted to form oligomers of four to six monomers.
An SDS resistant dimeric form of synaptogyrin 1 already indicated
that synaptogyrin 1 exists as a higher oligomer (Figure 6A).
Crosslinking experiments of synaptogyrin 1 in native membranes
and in its solubilised form (DDM and Triton were used as
detergents) with various crosslinkers suggest at least a tetrameric
assembly (Figure 7A, B, C). This is further supported by electron
microscopy. Synaptogyrin 1 preparations in DDM (Figure 8) are
highly homogenous without any obvious aggregation/precipita-
tion. Considering the membrane thickness of about 4–5 nm even
the smallest transmembrane protein need to show such a
dimension which is also the case here. The particle size of 5–
6 nm argues against oligomers higher than tetramers. Further-
more, the small, featureless shape indicates tight bundles of a-
helices as opposed to the 12–14 helices in the transporter DtpD
that displays an open crown like shape [43].
Figure 4. Detergent screening of synaptogyrin constructs. (A) Solubilisation efficiencies of synaptogyrin 1 constructs in different detergents
(SDS, FC12, DDM, DM, Triton X-100, LDAO and C12E8). Crude membranes solubilised in SDS were used as a reference and obtained Western blot signal
corresponds to 100 percent solubilisation efficiency. Only membranes with the highest expression levels for a particular constructs were used for this
solubilisation screen: (2) syn1b c1 (Rosetta2(DE3)); (2) syn1b c2 (Rosetta2(DE3)); (2) syn1b c4 (Rosetta2(DE3)); (2) syn1b c5 (Rosetta2(DE3)); (2)
syn1b c5 (Lemo21(DE3), 250 mM rhamnose). (B) Comparison of solubilisation efficiencies for the synaptogyrin 2 protein expressed in the (2)
Rosetta2(DE3) strain or (2) Lemo21(DE3) (100 mM rhamnose). (C) Relative solubilisation efficiencies of the synaptogyrin 3 protein expressed in the (2)
Rosetta2(DE3) strain or (2) Lemo21(DE3) (0 mM rhamnose). Error bars are derived from three independent Western blot analyses.
doi:10.1371/journal.pone.0038244.g004
Figure 5. Analytical gel filtration (AGF) screening of synaptogyrin. (A) Analytical gel filtration of different synaptogyrin 1 constructs after
solubilisation in DDM and subsequent IMAC purification. The void volume is indicated. Synaptogyrin 1 constructs elute as monodisperse peaks from
the gel filtration column indicative for high homogeneity: (2) syn1b c1; (2) syn1b c2; (2) syn1b c4; (2) syn1b c5. (B) Synaptogyrin 1b construct 5
remains stable and elutes as symmetrical peak from the analytical gel filtration column in different detergents ((2) DDM; (2) UDM; (2) DM; (2) LDAO;
(2) OG).
doi:10.1371/journal.pone.0038244.g005
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To further explore the folding state of the purified detergent
solubilised protein, we used NMR and CD spectroscopy (Figure 9).
The far UV-CD spectrum of synaptogyrin 1 (construct 5) reveals
the expected helical fold with more than 50% of the residues being
in an alpha helical conformation (Figure 9C). The one-
dimensional proton spectra as well as the heteronuclear
1H-
15N
TROSY-HSQC spectra show a reasonable dispersion within the
amid proton signal region (
1H=6 to 9 ppm, for the whole
temperature range used; Figure 9A,B). The very high field shifted
aliphatic resonance signal (
1H=20.4 ppm at 25 and 40uC,
Figure 9A) strongly indicates that synaptogyrin 1 is well folded.
Stability of synaptogyrin 1 was tested by heating the protein
sample up to 45uC and subsequent cooling to 25uC. Spectra
before and after heat treatment were virtually identical (data not
shown), indicating sufficient stability for structural studies.
Stability of synaptogyrin 1
To assess the thermal stability of synaptogyrin 1 we used
differential static light scattering (DSLS) in a 384 well format [44].
Upon unfolding, proteins, including IMPs, have a high tendency
for precipitation resulting in an increased light scattering signal.
Light scattering of synaptogyrin 1 in a variety of conditions (pH,
salt, detergents, lipids, and cholesteryl hemisuccinate) was followed
at increasing temperatures between 25 and 80uC. Figure 10A
shows that synaptogyrin 1 is significantly stabilised at neutral pH
and physiological concentrations of salt. The protein is further
stabilised upon addition of cholesteryl hemisuccinate. Whether
there is a direct interaction of cholesterol with synaptogyrin needs
to be shown, but synaptic vesicles are rich in cholesterol [13] and
cholesterol interaction has been proposed for the TVP synapto-
physin [15,16]. The presence of cholesteryl hemisuccinate does
neither significantly alter quality nor oligomeric state of the
purified protein as shown by analytical gel filtration experiments
(Figure 10B). Characteristic for eukaryotic proteins are often
disordered N- and C-terminal regions, which can hamper
crystallisation significantly. To address this issue, we used limited
proteolysis to study whether synaptogyrin 1 is susceptible for
proteolytic degradation. The entire protein remains stable and
folded in the presence of high concentrations of chymotrypsin.
Only the N-terminal His tag is cleaved within a short time period
as verified by mass spectrometry (Figure 10C).
Figure 6. Large scale expression of synaptogyrin 1. (A) SDS-PAGE from large scale purification of synaptogyrin 1b construct 5 over-expressed
in the Lemo21(DE3) strain in the presence of 250 mM rhamnose. High level expression and efficient IMAC beads binding results in a high yield of
recombinantly produced synaptogyrin 1. A potential dimeric form is indicated. (B) The IMAC purified protein elutes as a single monodisperse peak
from a preparative gel filtration column.
doi:10.1371/journal.pone.0038244.g006
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Despite their likely high importance in synaptic vesicles, the
elucidation of the functional role of TVPs remains challenging.
The problems with elucidating the exact cellular function is partly
due to the lack of phenotypes in knockout mice and C. elegans
[14,26–30]. To gain deeper insights into structure and functional
properties of human synaptogyrin we established the recombinant
production of homogeneous material in E. coli. In spite of that
relatively few human IMPs have previously been over-expressed in
the bacterial host E. coli, this study shows that screening
parameters such as construct design and bacterial expression
strain can be the key for successful production of high quality
material of human IMPs. Compared to the classical E. coli
BL21(DE3) strain an almost 50-fold increase in homogeneous
material per liter of culture could be obtained for synaptogyrin 1 in
the Lemo21(DE3) strain taking the increased expression level per
cell and biomass into account. Results of our initial over-
expression experiments pointed towards an important role of the
conflicting codon usage between the target gene and the bacterial
host. The E. coli strain Rosetta2(DE3) provides tRNAs for rare
codons in order to enhance the translation efficiency of ‘‘foreign’’
genes. It performed best for all initial constructs of the different
synaptogyrin isoforms tested. However, removing the codon
optimised N-terminal residues of the construct provided by the
vector backbone (compare construct 1–4, Figure 1) almost
completely abolished over-expression. Replacing these 12 addi-
tional N-terminal residues by a codon optimised His tag including
a TEV cleavage site restored almost 40% of the original expression
level. Therefore it seems more important to optimise the codon
usage for the N-terminal residues than for the whole gene to
guarantee an efficient translation start [45]. Based on previous
over-expression studies and the work presented here, slower
translation rates are preferred in order to balance expression speed
with the insertion process of the IMP into the membrane via the
Sec translocon (see [3]). So far optimisation of functional IMP
over-expression using codon optimised genes in E. coli has not
been systematically applied. Taking recent findings on transla-
tional rate and membrane insertion capacity into account it might
even be counterproductive [8,9]. In order to compare over-
expression levels of IMPs expressed under different conditions, or
as different constructs, it is essential to analyse the quality and
homogeneity of the over-expressed material. Unlike for soluble
protein, where incorrectly folded polypeptide chains usually end
up in inclusion bodies, IMPs can be targeted to the membrane and
end up as precipitated material in the membrane fraction.
Indication for this is the absolute requirement for harsh detergents
like SDS or FC12 to solubilise the target IMP. The solubilisation
efficiencies for synaptogyrin 1 are strongly dependent on the
construct used. Almost 100% of the N-terminally tagged
synaptogyrin 1 construct can be solubilised in a variety of mild
detergents while just half of the over-expressed material for the C-
terminally His tagged construct can be extracted in the same
detergents. We conclude that the destabilising effect of the
detergent upon extraction most likely is not the reason for reduced
extraction efficiency. Almost 50% of the C-terminally tagged
synaptogyrin polypeptide chains were not properly folded after
membrane insertion.
A variety of biophysical methods can be used to analyse the
folding state of IMPs. While NMR spectroscopy is a powerful tool
and gives more detailed information on sample quality, far UV-
CD spectroscopy requires much less purified material but provides
only information about the secondary structure of the protein.
This analysis tool also should be used with caution, since strong
detergents can induce helical structures indicating a properly
folded protein state. An example is the far UV-CD spectrum of the
beta barrel protein VDAC1, expressed as insoluble material in an
Figure 7. Crosslinking experiments of synaptogyrin 1 in the
presence of different bifunctional crosslinkers support an
oligomeric architecture. (A) Crosslinking of DDM solubilised and
purified synaptogyrin 1 in the presence of 0.25 mM DSS. (B) Higher
oligomeric species of synaptogyrin 1 are also obtained when the
crosslinking reaction (2 mM DMS) is performed on crude membranes.
(C) Similar conclusions result from crosslinking experiments of Triton X-
100 solubilised and purified material in the presence of 1 mM
glutaraldehyde. Crosslinking reactions were stopped after the given
time points by adding 200 mM of Tris solution and subsequent boiling
of the sample.
doi:10.1371/journal.pone.0038244.g007
Figure 8. Negative-stain TEM of single purified synaptogyrin 1
protein in the presence of the detergent DDM. The homogeneity
of the purified protein is reflected in the electron micrograph.
Synaptogyrin particles have a diameter of around 5–6 nm. The scale
bar represents 100 nm. Magnifications are shown.
doi:10.1371/journal.pone.0038244.g008
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where it shows the misleading signature of an alpha helical protein,
distinct from the native state [46]. Correctly refolded VDAC1
results in a CD spectrum expected for a protein rich in beta sheet
structures. The combination of both techniques (NMR- and CD
spectroscopy) deployed here for synaptogyrin 1 corroborate the
folded state of the recombinately over expressed protein.
Synaptogyrin 1 shows an expected alpha helical far UV-CD
spectrum and the heteronuclear
1H-
15N TROSY-HSQC spectra
has a reasonable dispersion within the amid proton signal region.
Although only about 80% of the expected signals are visible, the
spectrum has a fingerprint typical for folded proteins. The usage of
short chain detergents and the optimization of detergent to protein
ratio could help to improve the quality of the spectrum in the
future.
To determine the thermodynamic stability of IMPs against
chemical or temperature induced denaturation is problematic
since almost all IMPs denature in an irreversible manner.
However, apparent melting temperatures Tms can be determined
and used as measure of stability. Comparisons of Tms obtained
from different experiments have to be done carefully since they
depend on factors such as heating rate or protein concentration.
Batch to batch variations from IMP preparations resulting in
different lipid content and detergent concentration complicate the
situation further. Nevertheless, careful measurements of Tmso fa n
IMP in a multi-well plate format, as described here, allows for the
simultaneously detection of up to 384 conditions in a single
experiment, and can provide important information on stabilizing
parameters. Synaptogyrin 1 was most stable at neutral pH and
physiological concentrations of salt. Shorter chain detergents and
higher detergent concentrations reduced the stability, while the
addition of a mixture of brain lipids and cholesteryl hemisuccinate
stabilised the IMP further. Whether this is due to direct binding of
the lipids and cholesteryl hemisuccinate to synaptogyrin 1, needs
to be further established, but cholesterol binding to TVPs has been
reported previously [15,16].
Much remains to be learned about the biochemical and
physiological roles of synaptogyrin 1. The presented recombinant
over-expression, purification and biophysical characterisation of
synaptogyrin 1 and 2 provides a solid foundation for further
studies on this protein.
Materials and Methods
Materials and reagents
IPTG and all detergents were purchased from Affymetrix.
Luria-Bertani, Miller (LB) was from Becton Dickinson and Terrific
broth (TB) was from Formedium. Carbenicillin and chloram-
Figure 9. NMR- and CD-spectroscopy of synaptogyrin 1. (A) One-dimensional proton NMR spectra at two different temperatures as well as the
(B) heteronuclear
1H
15N TROSY-HSQC spectrum show a well dispersed amid proton signal region (
1H=6 to 9 ppm). The high field shifted aliphatic
resonance signals (
1H,0 ppm) strongly support a well folded protein state for synaptogyrin 1. (C) Far UV-CD spectrum of synaptogyrin 1 indicates a
high degree of alpha helical secondary structure with more than 50 percent of the residues being in an alpha helical conformation.
doi:10.1371/journal.pone.0038244.g009
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coli strain Lemo21(DE3) was from New England Biolabs. All other
chemicals were from Sigma, unless otherwise stated.
Gene construction
The genes coding for the three different synaptogyrin homo-
logues (Synaptogyrin 1, transcript variant 1b (BC000731),
synaptogyrin 2 (BC000407), synaptogyrin 3 (BC009568)) were
cloned into a pTH24 vector [47] via homologous recombination
(GatewayH cloning, Invitrogen) from the hORFeome collection
(http://hordb.dfci.hardvard.edu). For cleavage of the C-terminal
His tag a Tobacco Etch Virus (TEV) cleavage site was introduced
via blunt end PCR. For constructs three and four of synaptogyrin 1
nucleotides coding for the N-terminal residues of synaptogyrin
were removed by blunt end PCR. For the N-terminal His tag
construct (construct 5), the synaptogyrin 1 gene was cloned into
the pNIC28-Bsa4 vector using ligation independent cloning [48].
All vectors posses a T7 promoter and terminator sequence.
Expression was performed in five different E. coli strains:
BL21(DE3), BL21(DE3) pLysS, Rosetta2(DE3), C41(DE3),
C43(DE3) and Lemo21(DE3). BL21(DE3) is deficient of the Lon
protease and is lacking the outer membrane protease OmpT but
carries the lambda DE3 lysogen which expresses T7 RNA
polymerase from the lacUV5 promoter by IPTG induction. The
mutant strains C41(DE3) and C43(DE3) were derived from
BL21(DE3), selected for their improve over-expression perfor-
mances of toxic membrane proteins [41]. Rosetta2(DE3) is a host
strain that had been transformed with the plasmid pRARE2,
which provides tRNAs for seven codons (AGG, AGA, AUA,
CUA, CCC, GGA and CGG) rarely used in E. coli in order to
enhance the translation efficiency of genes with codons different
from endogenous E. coli ones [49]. Lemo21(DE3) is a BL21(DE3)
derivative, in which the activity of the T7 RNA polymerase can be
precisely controlled by its natural inhibitor T7 lysozyme [9].
Small scale protein over-expression
Cultures of 50 ml Terrific Broth (TB) medium in 300 ml baffled
conical flasks were inoculated from a Luria Bertani medium (LB)
over night culture to a start OD600 nm of 0.05 per ml and grown at
37uC at 200 rpm. At an OD600 nm 0.8–1.0 the temperature was
Figure 10. Stability dependence of synaptogyrin 1. (A) Thermal stability of synaptogyrin 1 was followed via differential static light scattering
(DSLS) in a 384 well plate format. The protein is most stable against heat denaturation at neutral pH and physiological concentrations of NaCl.
Examples of unfolding curves in three different conditions are shown. The stability is further enhanced in the presence of cholesteryl hemisuccinate.
(B) The analytical gel filtration profile is not significantly altered in the presence of 0.03 mg/ml brain lipids and 0.005% cholesteryl hemisuccinate. (2)
syn1b in 20 mM sodium phosphate, 150 mM NaCl, 5% glycerol, 0.03% DDM (2) syn1b in 20 mM sodium phosphate, 150 mM NaCl, 5% glycerol,
0.03 mg/ml brain lipids, 0.03% DDM, 0.005% cholesteryl hemisuccinate. (C) Limited proteolysis in the presence of chymotrypsin: Synaptogyrin 1
(construct 5) is stable against proteolytic degradation at a protein to protease ratio of 100:1. Only the N-terminal His tag is cleaved as verified by mass
spectrometry.
doi:10.1371/journal.pone.0038244.g010
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thiogalactopyranoside (IPTG) induction (200 mM). Cultures con-
tinued to grow for further 16 hours prior harvest. Cell density was
monitored by measuring the OD600 nm value. 40 ml of the cultures
were harvested at 5,000 g for six minutes and the pellets were
stored frozen at 280uC.
Membrane preparation
The frozen cell pellet was thawed on ice and resuspended in
15 ml lysis buffer (20 mM sodium phosphate, 300 mM NaCl,
pH 7.5, 0.5 mM DTT, 1 mg/ml lysozyme, 5 U/ml DNaseI and
one Complete Protease Inhibitor Cocktail tablet (EDTA free)
(Roche Applied Science) per 100 ml lysis buffer) and incubated
under stirring at 4uC for 45 minutes. Cells were lysed by
sonication (Sonifier, Branson Ultrasonics). Unbroken cells and
cell debris were removed by centrifugation at 10,000 g for 10 min
at 4uC and the membranes were collected by ultracentrifugation at
30,000 rpm (Beckman Ti45 rotor) at 4uC for 50 min. Membranes
were resuspended in 3 ml solubilisation buffer (20 mM sodium
phosphate, 300 mM NaCl, pH 7.5, 0.5 mM DTT, and EDTA-
free Protease Inhibitor cocktail) per 200 OD600 nm units and stored
at 280uC until further use.
SDS-PAGE and Western Blot analysis
The crude membrane samples were mixed and incubated with
reducing NuPAGEH LDS loading buffer (Invitrogen) at room
temperature and analyzed on 4–12% NuPAGEH Bis-Tris gels
(Invitrogen). SeeBlueH Plus2 Prestained standard (Invitrogen) or
BenchMark
TM Pre-stained (Invitrogen) were used as protein
markers for SDS-PAGE or Western blots, respectively. Proteins
were transferred onto nitrocellulose membranes using an iBlotH
Gel Transfer system (Invitrogen). Blots were blocked using 1%
BSA in TBS-T buffer (20 mM Tris pH 7.5, 100 mM NaCl,
0.05% (v/v) TweenH 20) for 1 hour at room temperature.
Membranes were washed 3 times for 10 minutes with TBS-T
buffer and then stained with a horseradish peroxidase-labelled His
probe (HisProbe
TM-HRP, Pierce) followed by SuperSignalH West
Pico chemiluminescent substrate (Pierce). Signals were detected
using a Fluor-S MultiImager (BioRad) CCD camera and
associated Quanti One software v.4.2.1.
Solubilisation and small-scale purification
Based on Western blot results, membranes were chosen for
small scale immobilized metal affinity chromatography (IMAC)
purification followed by analytical gel filtration runs. After thawing
membranes on ice, membranes were solubilised by addition of
different detergents (1% final concentration: SDS, FC12, DDM,
DM, Triton X-100, LDAO and C12E8). Samples were kept
shaking at 4uC for 60 minutes and were clarified by centrifugation
at 100,000 g for 30 minutes at 4uC before loading on IMAC resin.
IMAC purifications were performed in disposable Poly-Prep
Chromatography Columns (Bio-Rad) (0.8 by 4 cm). 125 ml Ni-
NTA agarose beads (Invitrogen) were added to the column and
equilibrated with 2 ml wash 1 buffer (20 mM sodium phosphate,
300 mM NaCl, pH 7.5, 30 mM imidazole pH 7.5, 0.5 mM DTT
and appropriate detergent. Ni
2+-beads were incubated with the
supernatant of solubilised membranes for 20 minutes at 4uC and
subsequently washed two times with 2 ml of wash 1 buffer,
followed by 262 ml of wash 2 buffer (20 mM sodium phosphate,
300 mM NaCl, pH 7.5, 40 mM imidazole pH 7.5, 0.5 mM DTT
and appropriate detergent. Protein was eluted with high concen-
tration of imidazole using 260.5 ml elution buffer (20 mM sodium
phosphate, 300 mM NaCl, pH 7.5, 400 mM imidazole, pH 7.5,
0.5 mM DTT and appropriate detergent). Elution fractions were
analysed on a SDS-PAGE and concentrated to 200 ml for
analytical gel filtration.
Analytical gel filtration
To assess the quality of the purified membrane protein
concentrated protein samples were analysed on an analytical gel
filtration column (Superdex 200 5/150 GL, GE Healthcare). To
guarantee reproducible and reliable gel filtration runs, an A ¨KTA
Explorer system (GE Healthcare) was coupled to an autosampler,
which automatically injected with high-precision 25 ml of protein
sample. Analytical gel filtration runs were performed in duplicates
in the cold room at a flow rate of 0.2 ml/min in gel filtration
buffer (20 mM HEPES pH 7.5, 300 mM NaCl, 0.5 mM DTT
with the appropriate detergent). Simultaneous absorption detec-
tion at 280 and 400 nm allowed distinction between the target
protein and some known IMAC contaminants that also absorb at
higher wavelength.
Large scale over-expression, purification and isotopic
labelling
Cultures of 500 ml Terrific Broth (TB) medium in 2.5 L baffled
conical flasks were inoculated from a Luria Bertani medium (LB)
over night culture and grown identically as the small scale cultures.
16 hours after induction with 0.2 mM IPTG, cells were harvested
at 5000 g for 10 minutes and the pellets were stored frozen at
280uC. 1 g of cell pellet (wet weight) was resuspended in 5 ml of
lysis buffer and incubated under stirring at 4uC for 45 minutes.
Cells were disrupted with an Emulsiflex microfluidizer at 15,000
p.s.i. chamber pressure. Unbroken cells and cell debris were
removed by centrifugation at 10,000 g for 10 min at 4uC and the
membranes were collected by ultracentrifugation at 30,000 rpm
(Beckman Ti45 rotor) at 4uC for 50 min. Membranes obtained
from 200 OD600 nm units were resuspended in 3 ml solubilisation
buffer (20 mM Na-P, 300 mM NaCl, pH 7.5, 0.5 mM DTT, and
EDTA-free Protease Inhibitor cocktail) and solubilised by the
addition of 1% dodecyl-ß-D-maltoside (DDM). After 60 min at
4uC, solubilised membranes were clarified by centrifugation at
29,000 rpm for 30 minutes at 4uC before loading on IMAC resin.
IMAC beads were incubated with the supernatant for 1 h and
loaded in a plastic column (Biorad) and washed with wash buffer
containing 20 mM and 40 mM imidazole, respectively. Purified
protein was eluted with 250 mM imidazole containing elution
buffer, dialysed against 20 mM sodium phosphate, 300 mM
NaCl, 5% glycerol, 0.5 mM DTT, 0.03% DDM together with
TEV protease over night. Cleaved membrane protein was passed
over IMAC beads again and the flow through was collected and
concentrated for final gel filtration in 20 mM HEPES, 150 mM
NaCl, 5% glycerol, 0.5 mM DTT, 0.03% DDM. Isotopically
labelled
15N NMR samples were produced using M9 minimal
media based on
15NH4Cl as nitrogen source (Cambridge Isotopes,





15N TROSY-HSQC NMR spectra were
acquired with a Bruker Avance III 800-MHz spectrometer using
a 5-mm cryoprobe with z-gradients in 20 mM sodium phosphate
buffer (pH 7.5), 150 mM NaCl, 0.5 mM DTT, 0.03% DDM,
containing 10%
2H2O at different temperatures. Protein concen-
tration was 0.4 mM for all measurements. A standard pulse
excitation sequence using the WATERGATE element [50] and
pre-saturation was used for one-dimensional proton spectra. Each
proton spectrum was recorded with 1024 transients. All two-
dimensional spectra were recorded using a sensitivity enhanced
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HSQC spectrum was recorded within 2 h 40 min. All
1H spectra
were processed and analysed by Topspin 2.1.
1H-
15N spectra were
processed by NMRPipe [52] and analysed by NMRView [53].
Equilibrium CD spectroscopy
All experiments were performed at 20uC in 20 mM sodium
phosphate buffer (pH 7.5), 150 mM NaCl, 0.5 mM DTT, 0.03%
DDM. CD spectra were recorded with a JASCO J600A
spectropolarimeter (0.1 cm cell length, 10 mM protein concentra-
tion, 1 nm bandwidth) and corrected for the buffer contributions.
Due to the high lipid content in the protein preparation Far UV-
CD spectra could only be recorded till 196 nm. Corrected CD
spectrum was analyzed with the online software package CDPro.
Thermal stability studies by DSLS
Thermal stability of synaptogyrin 1 was studied by differential
static light scattering (DSLS) using Stargazer (Harbinger Biotech-
nology and Engineering Corporation, Markham, Canada). Protein
stability is measured by monitoring protein aggregation upon
protein denaturation with increasing temperature at 600 nm.
Synaptogyrin 1 (construct 5) at 0.3 mg/ml in a 50 ml-volume in a
clear-bottom 384-well plate (Nunc) was heated from 25 to 80uCa t
1uC/min. Wells were covered with 50 ml mineral oil to minimize
evaporation. Protein aggregation was monitored and analysed as
described [44]. To study the influence of different buffers (pH 4–
9), salts (0–500 mM NaCl, 0–300 mM KCl, 0–20 mM CaCl2),
detergents and additives (as cholesteryl hemisuccinate and lipids)
on the aggregation behavior of synaptogyrin 1, purified protein
was diluted from a stock solution (10 mg/ml) into the new buffer
condition.
Electron microscopy
The synaptogyrin preparations were imaged by negative
staining as follows. Aliquots of 5 ml protein diluted to 20 mg/ml
were adsorbed on the carbon-film coated copper grids, washed
with 10 droplets of pure water and subsequently stained with 2%
uranyl-acetate. Images were recorded using a Philips CM100
TEM operated at 100 kV.
Crosslinking and limited proteolysis
Crosslinking experiments were performed at room temperature
on crude membranes and purified protein in the detergents DDM
and Triton X-100 according to the manufacturer instructions
(Invitrogen) using the crosslinkers DMS (Dimethyl suberimidate-
2HCl), DSS (Disuccinimidyl suberate) and glutaraldehyde. The
crosslinking reaction was quenched after different time points
upon addition of 200 mM Tris buffer. Samples were subsequently
analyzed on SDS-PAGE and Western blotting using a horseradish
peroxidase-labelled His probe. Stability of synaptogyrin 1 against
proteolytic degradation was performed on DDM purified protein
in the presence of different concentrations of chymotrypsin
(chymotrypsin: protein ratio: 1:100–1:10 000). Reaction was
stopped after different time points by heating the sample and
subsequent analysis on SDS-PAGE.
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